Stay updated on Pembrolizumab SBRT in TKI mRCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab SBRT in TKI mRCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. No changes visible in the study details content.
    Difference
    0.1%
    Check dated 2026-03-11T17:39:49.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Only visual styling changes were observed (header/footer and layout). The core study content, including eligibility criteria and outcomes, remains unchanged.
    Difference
    0.1%
    Check dated 2026-02-25T09:20:05.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the funding-lapse notice was removed. The change does not affect study design, eligibility criteria, endpoints, or locations.
    Difference
    0.5%
    Check dated 2026-02-11T02:23:19.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and NIH operations was added, and the document revision was updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.5%
    Check dated 2026-02-03T23:14:07.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI updates: added a Show glossary option and updated QC metadata labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with a new 'Revision: v3.4.0', while older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T21:54:04.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The Locations section was updated to add Alberta and Ontario locations and remove the former Alberta Locations and Ontario Locations entries, with the revision updated to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T07:58:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab SBRT in TKI mRCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.